Primary cells suppress oncogene-dependent apoptosis (original) (raw)

E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products

Brigitte Pützer

Cell Death & Differentiation, 2000

View PDFchevron_right

Adenovirus-Mediated Sensitization to the Cytotoxic Drugs Docetaxel and Mitoxantrone Is Dependent on Regulatory Domains in the E1ACR1 Gene-Region

Gunnel Hallden

PLoS ONE, 2012

View PDFchevron_right

E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents

Brigitte Pützer

Cancer research, 2000

View PDFchevron_right

E1A Oncogene-induced Sensitization of Human Tumor Cells to Innate Immune Defenses and Chemotherapy-induced Apoptosis in Vitro and in Vivo1,2

Tanya Miura

2003

View PDFchevron_right

Oncogene-dependent apoptosis is mediated by caspase-9

Yuri Lazebnik

Proceedings of the National Academy of Sciences, 1998

View PDFchevron_right

Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy

Gunnel Hallden

Oncogenesis, 2018

View PDFchevron_right

Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells

Ana Tari

Breast Cancer Research, 2007

View PDFchevron_right

Adenoviral inhibitors of the apoptotic cascade

Joanna Shisler

Trends in Microbiology, 1998

View PDFchevron_right

Getting Back on Track, or what to do when apoptosis is de-railed : Recoupling Oncogenes to the Apoptotic Machinery

Howard Fearnhead

Cancer Biology & Therapy, 2004

View PDFchevron_right

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

Iain McNeish, Joeri Aerts

Oncogene, 2008

View PDFchevron_right

E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells

Azemat Jamshidi-Parsian

Cancer Gene Therapy, 2004

View PDFchevron_right

Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death

Gustavo Amarante-mendes

Cell Death and Differentiation, 1998

View PDFchevron_right

Nitric Oxide-Induced Apoptosis Injury Sensitizes Cells to Macrophage Caspase2-Mediated Mitochondrial E1A Oncogene Enhancement of

Tanya Miura

View PDFchevron_right

Apoptosis and molecular targeting therapy in cancer

Mohamed Hassan

BioMed research international, 2014

View PDFchevron_right

Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation

William Bornmann

Oncogene, 2010

View PDFchevron_right

Induction of apoptosis by A3 adenosine receptor agonist N6-(3-iodobenzyl)-adenosine-5′-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism

Petr Mlejnek

Acta Physiologica, 2010

View PDFchevron_right

Gene expression profiles of normal human lung cells affected by adenoviral E1B

S. Waigel

Virology, 2006

View PDFchevron_right

Accumulation of p53 in response to adenovirus early region 1A sensitizes human cells to tumor necrosis factor alpha-induced apoptosis

Roger Grand

Virology, 2005

View PDFchevron_right

Adenoviral E1A everlasting tool versatile applications continuous contributions and new hypotheses

Nianli Sang

Frontiers in Bioscience, 2002

View PDFchevron_right

E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factor

Roberta Turner

Virology, 2014

View PDFchevron_right

Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells

Erasmus Schneider

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995

View PDFchevron_right

Conditionally Replicating Adenoviruses Kill Tumor Cells via a Basic Apoptotic Machinery-Independent Mechanism That Resembles Necrosis-Like Programmed Cell Death

Ida Van Der Meulen-muileman

Journal of Virology, 2004

View PDFchevron_right

E1A Sensitizes Cells to Tumor Necrosis Factor-induced Apoptosis through Inhibition of IκB Kinases and Nuclear Factor κB Activities

Mickey Hu

Journal of Biological Chemistry, 1999

View PDFchevron_right

Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53

Simon O’Carroll

Cancer research, 2000

View PDFchevron_right

Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models

Gunnel Hallden

Human Gene Therapy, 2012

View PDFchevron_right

The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells

Richard Marcellus

Oncogene, 2009

View PDFchevron_right

Modulation of cellular apoptotic potential: contributions to oncogenesis

James Woodgett

Oncogene, 1999

View PDFchevron_right

Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines

Brian O'Connell

Cancer Gene Therapy, 2002

View PDFchevron_right

Impact of E1a Modifications on Tumor-Selective Adenoviral Replication and Toxicity

Joan Reibman, J. Hay

Molecular Therapy, 2004

View PDFchevron_right

Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells

Santiago Ramon Y Cajal

Cancer gene …, 1999

View PDFchevron_right

Efficient Induction of Cell Death by Adenoviruses Requires Binding of E 1 B 55 k and p 531

Simon O’Carroll

2000

View PDFchevron_right

Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process

Jorge Almenara

Oncogene, 2004

View PDFchevron_right

Overexpression of adenovirus E3-11.6K protein induces cell killing by both caspase-dependent and caspase-independent mechanisms

Mark Horn

Virology, 2004

View PDFchevron_right

Direct activation of the apoptosis machinery as a mechanism to target cancer cells

Jenny Nguyen

Proceedings of the National Academy of Sciences of the United States of America, 2003

View PDFchevron_right

Role of apoptotic response in cellular resistance to cytotoxic agents

Federico Arcamone

Pharmacology & Therapeutics, 1997

View PDFchevron_right